IN-VIVO EVALUATION OF SPRAY FORMULATIONS OF HUMAN INSULIN FOR NASAL DELIVERY

被引:40
|
作者
DONDETI, P [1 ]
ZIA, HS [1 ]
NEEDHAM, TE [1 ]
机构
[1] UNIV RHODE ISL,COLL PHARM,DEPT PHARMACEUT,KINGSTON,RI 02881
关键词
INSULIN; HUMAN; NASAL ADMINISTRATION; SPRAY FORMULATION; BIOADHESIVE POLYMER; MICROCRYSTALLINE CELLULOSE; PLASTOID; AMMONIUM GLYCYRRHIZINATE; GLYCYRRHETINIC ACID; SODIUM TAUROCHOLATE;
D O I
10.1016/0378-5173(95)00045-K
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
There are many ongoing investigations to improve the nasal bioavailability of peptide and protein formulations. The presence of bioadhesive polymers in nasal formulations may increase the residence time of the drugs in the nasal cavity. A combination of bioadhesive polymers with permeation enhancers would seem to further improve nasal bioavailability. In this study, insulin spray formulations containing two bioadhesive polymers (1.5% w/v microcrystalline cellulose (MCC) and 70% w/w Plastoid L50) alone or in combination with the enhancers such as sodium taurocholate (ST), ammonium glycyrrhizinate (AG) or glycyrrhetinic acid (GA) at 1% w/v level, were evaluated in diabetic rabbits. A total volume of 100 mu l of freshly prepared insulin formulation was sprayed into the nasal cavity of each diabetic rabbit. Glucose levels were monitored using a blood glucose assay and serum insulin levels were analyzed using RIA. 5 U/kg insulin in the MCC suspension alone resulted in an absolute bioavailability of 1.96% while Plastoid L50 alone resulted in 2.25% absolute bioavailability. Insulin in the MCC suspension and ST, AG or GA resulted in 8.36, 7.83 and 2.15% bioavailability, respectively. The same formulations produced a hypoglycemic effect in terms of total glucose reductions of 39.12, 15.96 and 9.36% and the maximal decreases in glucose levels were 58.37, 21.8 and 18.61%, respectively. The Plastoid formulation containing 1% ST provided nasal insulin bioavailability of 5.9% with a total glucose reduction of 17.03% and a maximal glucose decrease of 26.56%. Insulin spray formulations containing 1% ST alone and 1% AG alone resulted in bioavailabilities of 7.25 and 3.57%, respectively. These same sprays provided total glucose reductions of 25.08 and 16.97% with maximal glucose decreases of 44.56 and 19.81%, respectively. The presence of benzalkonium chloride and 2-phenylethanol as preservatives in the MCC suspension resulted in higher insulin absorption than the same formulation without preservatives (6.31% vs 1.96%).
引用
收藏
页码:91 / 105
页数:15
相关论文
共 50 条
  • [41] Self-assembled insulin and nanogels polyelectrolyte complex (Ins/NGs-PEC) for oral insulin delivery: characterization, lyophilization and in-vivo evaluation
    Mudassir, Jahanzeb
    Darwis, Yusrida
    Muhamad, Suriani
    Khan, Arshad Ali
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2019, 14 : 4895 - 4909
  • [42] Nasal formulations for drug administration and characterization of nasal preparations in drug delivery
    Scherliess, Regina
    THERAPEUTIC DELIVERY, 2020, 11 (03) : 183 - 191
  • [43] Preparation and the in-vivo evaluation of paclitaxel liposomes for lung targeting delivery in dogs
    Zhao, Ling
    Ye, Yun
    Li, Juan
    Wei, Yu-meng
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2011, 63 (01) : 80 - 86
  • [44] Evaluation of a dose delivery verification system for in-vivo dosimetry in helical Tomotherapy
    Lesven, C.
    Losa, S.
    Francois, P.
    Mazal, A.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 (10) : 690 - 690
  • [45] Optimization of rivastigmine nanoemulsion for enhanced brain delivery: in-vivo and toxicity evaluation
    Haider, Md. Faheem
    Khan, Saba
    Gaba, Bharti
    Alam, Tausif
    Baboota, Sanjula
    Ali, Javed
    Ali, Asgar
    JOURNAL OF MOLECULAR LIQUIDS, 2018, 255 : 384 - 396
  • [46] Alkanoylsucroses in nasal delivery of low molecular weight heparins: in-vivo absorption and reversibility studies in rats
    Yang, TZ
    Mustafa, F
    Ahsan, F
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2004, 56 (01) : 53 - 60
  • [47] In-situ gel formulations of econazole nitrate: preparation and in-vitro and in-vivo evaluation
    Baloglu, Esra
    Karavana, Sinem Yaprak
    Senyigit, Zeynep Ay
    Hilmioglu-Polat, Suleyha
    Metin, Dilek Yesim
    Zekioglu, Osman
    Guneri, Tamer
    Jones, David S.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2011, 63 (10) : 1274 - 1282
  • [48] RELEASE AND ABSORPTION CHARACTERISTICS OF CHLORPHENESIN CARBAMATE SUSTAINED-RELEASE FORMULATIONS - IN-VITRO IN-VIVO AND IN-VIVO DOG-HUMAN CORRELATIONS
    AKIMOTO, M
    FURUYA, A
    NAKAMURA, M
    MAKI, T
    YAMADA, K
    SUWA, T
    OGATA, H
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 117 (01) : 31 - 39
  • [49] In Vivo Evaluation of Thiolated Chitosan Tablets for Oral Insulin Delivery
    Millotti, Gioconda
    Laffleur, Flavia
    Perera, Glen
    Vigl, Claudia
    Pickl, Karin
    Sinner, Frank
    Bernkop-Schnuerch, Andreas
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 103 (10) : 3165 - 3170
  • [50] Chitosan microspheres for pulmonary delivery of insulin:: in vivo evaluation in rats
    Carrión-Recio, D
    Remuñán-López, C
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 23 : S63 - S63